R&D/Clinical Trials

Latest News

Joel Latham, President and CEO of Incannex Healthcare Inc
Navigating the CBD Research Landscape: Unveiling Best Practices in the Post-MMCREA Era

March 14th 2024

Although research on cannabinoids is now allowed in a growing number of countries, there are still a number of restrictions and corresponding licenses and permits required to work with these chemicals.

Lexicon Aims to Resubmit New Drug Application for Type 1 Diabetes Treatment Sotagliflozin to the FDA Later This Year
Lexicon Aims to Resubmit New Drug Application for Type 1 Diabetes Treatment Sotagliflozin to the FDA Later This Year

March 14th 2024

Johnson & Johnson Submits Supplemental Biologics License Application to the FDA for Tremfya in Ulcerative Colitis Treatment
Johnson & Johnson Submits Supplemental Biologics License Application to the FDA for Tremfya in Ulcerative Colitis Treatment

March 13th 2024

EmpowerPharm Finishes Phase II Trial on Potential CBD Treatment for Social Anxiety Disorder
EmpowerPharm Finishes Phase II Trial on Potential CBD Treatment for Social Anxiety Disorder

March 12th 2024

Lisa Ricciardi
Finding the Right Patients: Q&A With Lisa Ricciardi, CEO of Cognition Therapies, Inc.

March 12th 2024

Video Interviews
Podcasts

More News